Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000805731 | SCV000945699 | pathogenic | Methylcobalamin deficiency type cblE | 2018-10-07 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in MTRR are known to be pathogenic (PMID: 15714522). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has not been reported in the literature in individuals with MTRR-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Tyr91Metfs*20) in the MTRR gene. It is expected to result in an absent or disrupted protein product. |
Baylor Genetics | RCV003467413 | SCV004198759 | likely pathogenic | Neural tube defects, folate-sensitive | 2023-07-06 | criteria provided, single submitter | clinical testing |